Company / Depreciation & Amortization
Celularity Inc Depreciation & Amortization History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$7.3M
FY2025
5-year range
$7.3M / $9.4M
FY2021-FY2025
Trend
-7.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Depreciation & Amortization has declined for 3 consecutive years, from $9M in FY2022 to $7M in FY2025.
Based on SEC 10-K filings.
$7M in FY2025 with a 3-year CAGR of -8.2%.
Improved from $9M to $7M over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -8.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Celularity Inc's depreciation & amortization has declined for 3 consecutive years.
- 3-year CAGR of -8.2%, indicating a declining trend.
- In FY2025, depreciation & amortization decreased 7.9% year-over-year.
- Peak depreciation & amortization was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -9.92 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.3M | -7.9% |
| FY2024 | $7.9M | -15.0% |
| FY2023 | $9.3M | -1.2% |
| FY2022 | $9.4M | +7.0% |
| FY2021 | $8.8M | - |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026